| This policy brief addresses the challenges faced by the Philippine FDA in regulating food and household hazardous substances. It highlights institutional inefficiencies, bureaucratic delays, and stakeholder concerns regarding product registration. The brief proposes recommendations to enhance the FDA's regulatory capacity and efficiency, emphasizing the need for improved processes, addressing backlogs, and fostering greater collaboration with stakeholders to ensure public health safety and streamline regulatory functions. |